X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2370) 2370
Book Review (710) 710
Publication (229) 229
Newsletter (49) 49
Conference Proceeding (13) 13
Book Chapter (7) 7
Magazine Article (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2016) 2016
humans (2000) 2000
thalidomide (1362) 1362
multiple myeloma (1361) 1361
multiple myeloma - drug therapy (1288) 1288
hematology (1160) 1160
oncology (1159) 1159
male (1037) 1037
bortezomib (1003) 1003
aged (976) 976
female (969) 969
middle aged (952) 952
thalidomide - analogs & derivatives (941) 941
lenalidomide (818) 818
antineoplastic combined chemotherapy protocols - therapeutic use (765) 765
thalidomide - administration & dosage (761) 761
thalidomide - therapeutic use (706) 706
dexamethasone (692) 692
treatment outcome (681) 681
stem-cell transplantation (675) 675
adult (625) 625
therapy (556) 556
dexamethasone - administration & dosage (534) 534
chemotherapy (490) 490
thalidomide - adverse effects (464) 464
antineoplastic agents - therapeutic use (453) 453
care and treatment (444) 444
survival (428) 428
multiple myeloma - mortality (414) 414
aged, 80 and over (399) 399
plus dexamethasone (392) 392
multiple myeloma - therapy (389) 389
antineoplastic combined chemotherapy protocols - adverse effects (336) 336
transplantation (335) 335
multiple myeloma - pathology (334) 334
cancer (316) 316
disease-free survival (298) 298
melphalan (295) 295
recurrence (283) 283
elderly-patients (272) 272
lenalidomide plus dexamethasone (271) 271
drug therapy (266) 266
medicine & public health (255) 255
boronic acids - administration & dosage (244) 244
prognosis (243) 243
pyrazines - administration & dosage (243) 243
multiple myeloma - diagnosis (242) 242
transplantation, autologous (239) 239
trial (236) 236
prednisone (233) 233
combination (222) 222
retrospective studies (221) 221
research (217) 217
antineoplastic combined chemotherapy protocols - administration & dosage (216) 216
hematology, oncology and palliative medicine (216) 216
survival analysis (213) 213
thalidomide plus dexamethasone (213) 213
stem cells (209) 209
combination therapy (207) 207
multiple-myeloma (206) 206
pharmacology & pharmacy (203) 203
boronic acids - therapeutic use (201) 201
pyrazines - therapeutic use (201) 201
dexamethasone - therapeutic use (199) 199
survival rate (196) 196
myeloma (195) 195
stem cell transplantation (194) 194
analysis (193) 193
abridged index medicus (190) 190
antineoplastic agents - adverse effects (185) 185
dosage and administration (170) 170
thalidomide - pharmacology (170) 170
multiple myeloma - complications (167) 167
immunologic factors - therapeutic use (165) 165
remission induction (163) 163
risk factors (162) 162
clinical trials as topic (161) 161
dexamethasone - adverse effects (161) 161
hematopoietic stem cell transplantation (159) 159
angiogenesis inhibitors - therapeutic use (158) 158
clinical trials (155) 155
cyclophosphamide (154) 154
follow-up studies (153) 153
health aspects (153) 153
newly-diagnosed myeloma (152) 152
antineoplastic agents - administration & dosage (149) 149
drug therapy, combination (146) 146
patients (145) 145
animals (144) 144
salvage therapy (141) 141
disease progression (139) 139
high-dose therapy (139) 139
angiogenesis inhibitors (137) 137
melphalan - administration & dosage (137) 137
drug administration schedule (136) 136
combined modality therapy (133) 133
patient outcomes (132) 132
refractory multiple-myeloma (132) 132
autologous transplantation (131) 131
dose-response relationship, drug (131) 131
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2368) 2368
French (22) 22
German (11) 11
Japanese (9) 9
Chinese (6) 6
Polish (5) 5
Spanish (4) 4
Czech (2) 2
Dutch (1) 1
Korean (1) 1
Russian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 438 - 447
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 21, pp. 2123 - 2132
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2007, Volume 357, Issue 21, pp. 2133 - 2142
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9758, pp. 2075 - 2085
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 22, pp. 5752 - 5758
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2010, Volume 28, Issue 30, pp. 4621 - 4629
Journal Article
Journal Article
Blood, ISSN 0006-4971, 02/2010, Volume 115, Issue 7, pp. 1343 - 1350
Journal Article